Clinical Trial Update: A Study of CUSP06 in Patients With Platinum-Refractory/Resistant Ovarian Cancer and Other Advanced Solid Tumors [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating CUSP06 in patients with platinum-refractory/resistant ovarian cancer and other advanced solid tumors is currently recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer
• Solid Tumors

Drugs mentioned

• CUSP06

Snippet

Sponsor: OnCusp Therapeutics, Inc. | Conditions: Ovarian Cancer, Solid Tumor | Phase 1 | Status: RECRUITING